This is complete garbage. Company and stock toast? Based on what shorty? Based on your comment? I look at a population in phase 3, where the equivalent population in phase 2 had probably an HR of around .70, with a p-value of around .003. That sounds like approval to me. And Enchant and the new IP is free at this price. You are just another clown jumping on the fools bandwagon.
Over 80% of the total short position entered into below the current share price. That should give you all something to think about when you question who is really in control here. The shorts are out of control, and they are doubling down again and again to try to limit their losses. All they do is increase their exposure. The smart ones are getting out by sucking in new retail shorts to help them cover. Shorts do not control here. It is an unfortunate illusion for them to believe and try to make the market believe.
I have been saying this is a squeeze in the making. All great squeezes have one thing in common - shorts run the show on sentiment and double down again and again to keep sentiment low and the share price lower. Then a catalyst happens, or sometimes the shorts simply break ranks when a portion of the short pack decides not to double down any more and just call it a day, and then the squeeze happens. Usually retailers (you and I) have no idea what is going on, the shares can just be quoted 100% higher in premarket one day on no news. This isn't dreaming, it isn't hype, it is reality. All it sometimes takes is a big fund short the shares having a meeting with someone over the weekend who tells them that something is up at the company or that it is time to get out. Then come Monday the shares gap up 100% and the squeeze is on. That is the way it works. And this is the most heavily shorted stock on Nasdaq as a % of the outstanding shares and float. So just be patient, the squeeze is coming and it will hit like a Mack truck filled with bricks and steel.
The phone line is down! LOL The odds for successful phase 3 are in the longs favour. Don't believe the short hype.
You are being a fool. That cash will be burnt shortly, you only play into the hands of shorts by centering the argument around silly points that suit them. Cash is not an issue here, neither is dilution. ALL pre revenue biotechs factor in expected dilution into their share prices. The share price here is not based on cash or fear of not getting cash. The share price is based on IP and expected potential revenue in the market. That is the way it works. Just take the current share price as a gift and buy. The ones who benefit from this are the long term longs who hold and get to add to their cost basis at a lower price thanks to silly shorts (who will cover at higher levels).
He decimated shorts in the US GOVT BOND MARKET. And a bunch of silly jokers like you following AF think that he doesn't have a plan to do a 100 times worse to you than he did to the shorts in the bond market? What stupidity on your part.
What good is it to be able to short and drive down the share price if chances are you can not cover without driving the share price back up and beyond where you shorted. That is the problem here for shorts.
The only party that benefits is the long who adds to his position at a lower cost basis.
So contrary to shorts being in control, they are out of control and helping longs. That is the truth.
And then there is the squeeze to come. Even more pain for shorts. And more gain for longs.
Shorts prey on perceived weakness and doubt. Remove the perceived weakness and doubt, and they have to cover when the shares are undervalued. Very simple.
No the parntnership is not for money. The money is nice. It is for the credibility. The minute a credible player, especially big pharma, does a deal with Synta, then 99% of the short argument goes out the window in a heartbeat. Because the argument will suddenly become a long one, that is, if (fill in blank with big Pharma name) did a deal with Synta, then why should I believe you that the company is not for real?
I would say that makes it simple and makes it a slam dunk.
And your friend AF won't save you - he is too concerned with trying to get his hedge fund buddies out of their stupid short positions. The more he bashes, the more his friends get out at the expense of retail shorts. But his buddies have so many shares short that they are doomed also.
The short trade is about done here, and it will end in tears for the shorts.
And if half of them decided to throw in the towel, that will be really wonderful for the longs. You will all be very surprised at how quickly this could meet and exceed that 27 price target of Roth.
The bleeding will stop on its own before then. But the partnership would start the squeeze. That takes us to over 10 in a heartbeat, in half a day.